Ernie Mario

Track

Insider profile

Currently holds positions in Hyperion DeFi Inc, Soleno Therapeutics Inc and Kindred Biosciences Inc

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 37% 68% 82%
Transactions
9 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Hyperion DeFi Inc None -
Independent Chairman of the Board Soleno Therapeutics Inc Feb. 1, 2014 -
Independent Director Kindred Biosciences Inc April 2, 2018 -
Independent Director Celgene Corp Aug. 22, 2007 - Nov. 20, 2019
Independent Director Tonix Pharmaceuticals Holding Corp Oct. 14, 2011 - Sept. 5, 2018
Independent Chairman of the Board Chimerix Inc Feb. 1, 2013 - June 1, 2018
Independent Director Kindred Biosciences Inc Feb. 15, 2013 - May 23, 2016
Independent Director Boston Scientific Corp Oct. 30, 2001 - April 15, 2016
Lead Independent Director Pharmaceutical Product Development Inc July 1, 2009 - Jan. 1, 2016
Director XenoPort Inc June 15, 2012 - May 19, 2015
Chairman & CEO Soleno Therapeutics Inc Aug. 1, 2007 - Feb. 1, 2014
Independent Director Maxygen Inc July 20, 2001 - Aug. 29, 2013
Independent Director Vivus Inc April 18, 2012 - July 19, 2013
Ernie Mario's trades of Soleno Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-04 2022-03-31
B Purchase
79,116
327.06
US$2,775,769 		79,116 327.06 US$2,775,769
2022-04-04 2022-03-31
B Purchase
45,641
14.80
US$4,568,918 		45,641 14.80 US$4,568,918
2020-03-26 2020-03-24
B Purchase
71,373 -22.3%
324.63
US$1,240,053 		71,373 -22.3% 324.63 US$1,240,053
2019-07-15 2019-07-11
B Purchase
35,971 +15.2%
2.78
US$99,999 		35,971 +15.2% 2.78 US$99,999
2019-02-14 2019-02-12
US Celgene Corp (CELG)
B Purchase
2,000 +inf%
89.99
US$179,980 		2,000 +inf% 89.99 US$179,980
2019-05-21 2018-01-29
B Purchase
90,000 +61.3%
10.00
US$900,000 		90,000 +61.3% 10.00 US$900,000
2016-12-29 2016-12-27
US Chimerix Inc (CMRX)
PlS Planned sale
72,073 -19.6%
4.68
US$337,143 		72,073 -19.6% 4.68 US$337,143
2016-08-19 2016-08-18
B Purchase
25,000 +1.4%
0.99
US$24,750 		25,000 +1.4% 0.99 US$24,750
2016-05-23 2016-05-20
B Purchase
5,637 +0.3%
1.20
US$6,764 		5,637 +0.3% 1.20 US$6,764
2015-08-25 2015-08-21
B Purchase
16,228 +1.1%
1.91
US$30,995 		16,228 +1.1% 1.91 US$30,995
2015-08-12 2015-08-11
B Purchase
50,000 +3.9%
1.77
US$88,500 		50,000 +3.9% 1.77 US$88,500
2004-05-05 2004-05-05
B Purchase
20,000 +39.7%
13.00
US$260,000 		20,000 +39.7% 13.00 US$260,000
2004-05-06 2004-05-04
B Purchase
500 +0.5%
39.86
US$19,930 		500 +0.5% 39.86 US$19,930
2004-05-06 2004-05-04
B Purchase
2,200 +2.1%
39.85
US$87,670 		2,200 +2.1% 39.85 US$87,670